Novel unit B cryptophycin analogues as payloads for targeted therapy

Eduard Figueras, Adina Borbély, Mohamed Ismail, Marcel Frese and Norbert Sewald
Beilstein J. Org. Chem. 2018, 14, 1281–1286. https://doi.org/10.3762/bjoc.14.109

Supporting Information

Supporting Information File 1: Experimental part and analytical data.
Format: PDF Size: 3.9 MB Download

Cite the Following Article

Novel unit B cryptophycin analogues as payloads for targeted therapy
Eduard Figueras, Adina Borbély, Mohamed Ismail, Marcel Frese and Norbert Sewald
Beilstein J. Org. Chem. 2018, 14, 1281–1286. https://doi.org/10.3762/bjoc.14.109

How to Cite

Figueras, E.; Borbély, A.; Ismail, M.; Frese, M.; Sewald, N. Beilstein J. Org. Chem. 2018, 14, 1281–1286. doi:10.3762/bjoc.14.109

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 2.4 MB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Hofmann, S.; Dombrowsky, C.; Happel, D.; Dessin, C.; Cermjani, E.; Cica, M.; Avrutina, O.; Sewald, N.; Neumann, H.; Kolmar, H. Conditional Cell Penetration of Masked CPPs by an ADEPT-like Approach. ACS chemical biology 2024, 19, 1320–1329. doi:10.1021/acschembio.4c00149
  • Paulus, J.; Sewald, N. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment. Journal of peptide science : an official publication of the European Peptide Society 2024, 30, e3561. doi:10.1002/psc.3561
  • Moschona, F.; Savvopoulou, I.; Tsitopoulou, M.; Tataraki, D.; Rassias, G. A. Epoxide Syntheses and Ring-Opening Reactions in Drug Development. Catalysts 2020, 10, 1117. doi:10.3390/catal10101117
  • Thuan, N. H.; An, T. T.; Shrestha, A.; Canh, N. X.; Sohng, J. K.; Dhakal, D. Recent Advances in Exploration and Biotechnological Production of Bioactive Compounds in Three Cyanobacterial Genera: Nostoc, Lyngbya, and Microcystis. Frontiers in chemistry 2019, 7, 604. doi:10.3389/fchem.2019.00604
  • Borbély, A.; Figueras, E.; Martins, A.; Bodero, L.; Dias, A. R. M.; Rivas, P. L.; Pina, A.; Arosio, D.; Gallinari, P.; Frese, M.; Steinkühler, C.; Gennari, C.; Piarulli, U.; Sewald, N. Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen 2019, 8, 737–742. doi:10.1002/open.201900110
  • Figueras, E.; Martins, A.; Borbély, A.; Le Joncour, V.; Cordella, P.; Perego, R.; Modena, D.; Pagani, P.; Esposito, S.; Auciello, G.; Frese, M.; Gallinari, P.; Laakkonen, P.; Steinkühler, C.; Sewald, N. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics 2019, 11, 220. doi:10.3390/pharmaceutics11050220
  • Borbély, A.; Figueras, E.; Martins, A.; Esposito, S.; Auciello, G.; Monteagudo, E.; Di Marco, A.; Summa, V.; Cordella, P.; Perego, R.; Kemker, I.; Frese, M.; Gallinari, P.; Steinkühler, C.; Sewald, N. Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics 2019, 11, 151. doi:10.3390/pharmaceutics11040151
  • Cazzamalli, S.; Figueras, E.; Pethő, L.; Borbély, A.; Steinkühler, C.; Neri, D.; Sewald, N. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS omega 2018, 3, 14726–14731. doi:10.1021/acsomega.8b02350
Other Beilstein-Institut Open Science Activities